COVID-19 and nicotine as a mediator of ACE-2
Eur Respir J
.
2020 Jun 4;55(6):2001261.
doi: 10.1183/13993003.01261-2020.
Print 2020 Jun.
Authors
Janice M Leung
1
2
,
Chen Xi Yang
1
,
Don D Sin
3
2
Affiliations
1
Centre for Heart Lung Innovation, University of British Columbia, Vancouver, BC, Canada.
2
Division of Respiratory Medicine, Dept of Medicine, St. Paul's Hospital, Vancouver, BC, Canada.
3
Centre for Heart Lung Innovation, University of British Columbia, Vancouver, BC, Canada Don.Sin@hli.ubc.ca.
PMID:
32350104
PMCID:
PMC7191112
DOI:
10.1183/13993003.01261-2020
Abstract
α7-nAChR may upregulate ACE-2
https://bit.ly/2xS0cfT
Publication types
Letter
Comment
MeSH terms
Betacoronavirus
COVID-19
Coronavirus Infections
Humans
Nicotine*
Pandemics
Pneumonia, Viral
Pulmonary Disease, Chronic Obstructive*
SARS-CoV-2
Smokers
Substances
Nicotine